Crowdonomics
All companies
GEROSTATE ALPHA (YC S18) logo

GEROSTATE ALPHA (YC S18)

Operating

Gerostate Alpha Inc.

Biotech · Founded 2018

A pharmaceutical company dedicated to treating aging and age-related disease

Valuation cap ⓘ
$20.0M
As of Nov 2021 · from Reg CF Offering (2021-10-05) · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$523,545
Across 3 rounds since 2021

Financials

FY2019–FY2021 · from SEC filings · hover any figure for its source
$0
−$922K
2019
$0
−$641K
2020
$0
−$332K
2021
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019 audited*
FY2020 audited*
FY2021
Income statement
Revenue
$0
$0
$0
Cost of goods sold
$0
$0
$0
Net income
-$922,032
-$640,862
-$332,457
Taxes paid
$872
$872
$800
Balance sheet
Cash
$627,109
$302,791
$712,508
Accounts receivable
$0
$0
$0
Total assets
$752,475
$414,210
$767,986
Short-term debt
$51,048
$48,845
$45,353
Long-term debt
$0
$54,800
$0
Total liabilities
$51,048
$103,645
$45,353
Other
Headcount
—
1
1

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Valuation caps on SAFE / convertible note rounds
$15.0M
Valuation cap
$20.0M
Valuation cap
Reg CF · SAFE · Jul 2021
Reg CF · SAFE · Oct 2021

Dashed amber bars are a SAFE or convertible note's valuation cap — the most it converts at, not what the company is worth.

Fundraising history

Gerostate Alpha (YC S18)Closedvia WeFunder
Raised — / $1.1M
Reg CF · SAFE · Oct 2021Closedvia WeFunder
Raised $252.7K / $4.5MValuation cap $20M
Reg CF · SAFE · Jul 2021Closedvia WeFunder
Raised $270.9K / $1.1MInvestors 346Valuation cap $15M

Team

3 people
Simon Melov
CEO
Mark Lucanic
CTO
Gordon J Lithgow
Fellow

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 1 of 5 annual reports (FY2021–FY2025)

Missing: 2022, 2023, 2024, 2025

346 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARApr 28, 20220001670254-22-000425
    EDGAR
  • Form C-UOct 5, 20210001670254-21-001115
    EDGAR
  • Form COct 5, 20210001670254-21-001118
    EDGAR
  • Form CJul 20, 20210001670254-21-000844
    EDGAR
Source: ManualCIK 0001858392

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.